Journal Home
Search for

Volume 55, Issue 2, Pages 198-200 (February 2010)


View previous. 14 of 29 View next.

Breath Alcohol Analyzer Mistakes Methanol Poisoning for Alcohol Intoxication

Presented at the North American Congress of Clinical Toxicology meeting, October 2006, San Francisco, CA.

E. Martin Caravati, MD, MPHabCorresponding Author Informationemail address, Kathleen T. Anderson, PharmDa

Received 8 May 2009; received in revised form 15 July 2009; accepted 22 July 2009. published online 15 October 2009.

Breath alcohol analyzers are used to detect ethanol in motorists and others suspected of public intoxication. One concern is their ability to detect interfering substances that may falsely increase the ethanol reading. A 47-year-old-man was found in a public park, acting intoxicated. A breath analyzer test (Intoxilyzer 5000EN) measured 0.288 g/210 L breath ethanol, without an interferent noted. In the emergency department, the patient admitted to drinking HEET Gas-Line antifreeze, which contains 99% methanol. Two to three hours after ingestion, serum and urine toxicology screen results were negative for ethanol and multiple other substances. His serum methanol concentration was 589 mg/dL, serum osmolality 503 mOsm/kg, osmolar gap 193 mOsm/kg, and anion gap 17 mmol/L. The patient was treated with intravenous ethanol, fomepizole, and hemodialysis without complication. This is a unique clinical case of a breath alcohol analyzer reporting methanol as ethanol. Intoxilyzer devices have been shown to indicate some substances (acetone) as interferents in humans but not methanol. Increased serum concentrations of methanol can be reported as ethanol by a commonly used breath alcohol analyzer, which can result in a delayed diagnosis or misdiagnosis and subsequent methanol toxicity if antidotal treatment is not administered in a timely manner.

a Utah Poison Control Center, University of Utah, Salt Lake City, UT

b Division of Emergency Medicine, University of Utah, Salt Lake City, UT

Corresponding Author InformationAddress for correspondence: E. Martin Caravati, MD, MPH, 585 Komas Drive, Suite 200, Salt Lake City, UT 84108; 801-587-0600, fax 801-581-4199

 Supervising editor: Richard C. Dart, MD, PhD

 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article that might create any potential conflict of interest. The authors have stated that no such relationships exist. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement.

 Publication date: Available online October 14, 2009.

 Reprints not available from author.

PII: S0196-0644(09)01280-3

doi:10.1016/j.annemergmed.2009.07.021


View previous. 14 of 29 View next.